CD86 and colitis: In PPs, administration of the probiotic mixture to mice with colitis significantly decreased the frequencies of CD83+ (p < 0.05) (Figure 5G), CD86+ (p < 0.01) (Figure 5I), and CD11c+ cells (p < 0.01) (Figure 5J) compared to untreated colitis mice.